Clinical trial
Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
NCT00428519 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00428519 |
|---|---|
| Title | Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals |
| Official title | A Phase Ib, Randomized, Placebo Controlled, Double Blind Study to Determine the Safety, Viral Suppression, Pharmacokinetics and Immune Modulatory Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Placebo, Aprepitant |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 30, 2007 |
| Last update posted | Mar 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: